MedTrace Logo

Cross-cultural Adaptation and Validation of the French Version of the Social Media Disorder Scale for Parents in a Sample of Parents of Children Aged 10 to 17

NCT07476755 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-03-17

No results posted yet for this study

Summary

During the first lockdown related to the COVID-19 crisis, more than 12 million students in France were affected by school closures. Previous studies have shown that when children and adolescents are not in school, they are less physically active, spend more time in front of screens, and have disrupted sleep patterns. Parents are often the first to notice problems with their children's misuse of social media, and children tend to underestimate how often and how long they use social media. Therefore, given the increase in social media use and the limitations of self-assessment scales, it seems necessary to supplement the identification of problematic social media use in children with parental hetero-assessments.

The main objective of the research is to translate, culturally adapt into French, and validate the parent version of the Social Media Disorder Scale (SMDS-P).

The secondary objectives are 1) to determine the degree and meaning of discrepancies in the scores for problematic social media use obtained by the parent-child pair, and 2) to study the socio-demographic, clinical, and environmental factors associated with problematic social media use (according to the SMDS score) among preteens and teens.

The population of interest consists of parent/children pairs aged 10 to 17. This population is recruited from consultants in the pediatrics and child psychiatry departments of the Centre Hospitalier de Versailles.

This is a cross-sectional observational epidemiological study.

Conditions

  • Problematic Social Media Use

Sponsors & Collaborators

  • Versailles Hospital

    lead OTHER

Eligibility

Min Age
10 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-31
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07476755 on ClinicalTrials.gov